To minimize potential damage from underground oil and gas leaks, Oak Ridge National Laboratory is co-developing a quantum sensing system to detect pipeline leaks more quickly.
Scientists at Oak Ridge National Laboratory added new plant data to a computer model that simulates Arctic ecosystems, enabling it to better predict how vegetation in rapidly warming northern environments may respond to climate change.
Researchers working with Oak Ridge National Laboratory developed a new method to observe how proteins, at the single-molecule level, bind with other molecules and more accurately pinpoint certain molecular behavior in complex
Scientists studying a unique whole-ecosystem warming experiment in the Minnesota peatlands found that microorganisms are increasing methane production faster than carbon dioxide production.
Equipment and expertise from Oak Ridge National Laboratory will allow scientists studying fusion energy and technologies to acquire crucial data during landmark fusion experiments in Europe.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
Deborah Frincke, one of the nation’s preeminent computer scientists and cybersecurity experts, serves as associate laboratory director of ORNL’s National Security Science Directorate. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy
At the Department of Energy’s Oak Ridge National Laboratory, scientists use artificial intelligence, or AI, to accelerate the discovery and development of materials for energy and information technologies.
When COVID-19 was declared a pandemic in March 2020, Oak Ridge National Laboratory’s Parans Paranthaman suddenly found himself working from home like millions of others.
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.